drugset / Trial / NCT03202459

Prophylaxy of Postoperative Nausea and Vomiting in Patients Undergoing Laparoscopic Surgery

NCT03202459

RandomizedParallel-groupDouble-blindOther

Summary

Postoperative nausea and vomiting (PONV) is one of the most commonly reported adverse effects of anesthesia. The general incidence of vomiting is approximately 30%, nausea at 50% and the PONV rate can go up to 80% in high-risk patients without prophylaxis. Prevention of these episodes in high-risk patients improves satisfaction and well-being rates. Therefore, it becomes important the adequate control of PONV, aiming at the satisfaction of the patient with the procedure, lower costs for the health system as well as reduction of complications in the postoperative period. This study aims to evaluate the association of gabapentin or pregabalin with dexamethasone in reducing the incidence of PONV in high-risk patients undergoing laparoscopic surgeries in the first 48 hours postoperatively as well as to assess side effects.

Timeline

Start
2017-03-02
Primary completion
2017-09-30
Completion
2018-01-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Gabapentin Small molecule 600 mg Oral
Comparator Pregabalin Small molecule 150 mg Oral
Comparator Ondansetron Other / unclassified 8 mg Intravenous

Indications

No indication recorded.